Brief: Mink Therapeutics To Report Fourth Quarter And Full Year 2025 Financial Results And Highlight Platform Expansion Across Inkt Cell Therapy Programs
17/03/2026 11:40
March 17 (Reuters) - Mink Therapeutics Inc INKT.O: MINK THERAPEUTICS TO REPORT FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND HIGHLIGHT PLATFORM EXPANSION ACROSS INKT CELL THERAPY PROGRAMS Source text: ID:nGNX8YgP5L Further company coverage: INKT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's